Home > Insider Trading > Filing (0001209191-19-055017)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720725	Oyster Point Pharma Inc.	OYST	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1005561	J Peter Barris	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1219871	M David Mott	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1237289	D Scott Sandell	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1277631	Forest Baskett	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1544328	New Enterprise Associates 14, L.p.	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1551531	Nea Partners 14, L.p.	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1551532	Nea 14 Gp, Ltd	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1559807	W. Peter Sonsini	2855 Sand Hill Road Menlo Park CA 94025	No	No	Yes	No
1559827	Jr. A. Anthony Florence	5425 Wisconsin Avenue Suite 800 Chevy Chase MD 20815	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	3,606,282	$0.00	3,928,740	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	1,061,547	$0.00	4,990,287	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	935,000	$16.00	5,925,287	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001 Per Share	Series A Convertible Preferred Stock	Disposition	2019-11-04	3,606,282	$0.00	3,606,282	$0.00
Common Stock, Par Value $0.001 Per Share	Series B Convertible Preferred Stock	Disposition	2019-11-04	1,061,547	$0.00	1,061,547	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date.
The securities are directly held by New Enterprise Associates 14, L.P., ("NEA 14") and are indirectly held by NEA Partners 14, L.P. ("NEA Partners 14"), the sole general partner of NEA 14, NEA 14 GP, LTD ("NEA 14 LTD"), the sole general partner of NEA Partners 14 and each of the individual directors of NEA 14 LTD (NEA Partners 14, NEA 14 LTD and the individual directors of NEA 14 LTD (collectively, the "Directors") together, the "Indirect Reporting Persons"). The Directors of NEA 14 LTD are Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., David M. Mott, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 securities in which the Indirect Reporting Persons have no pecuniary interest.